4.7 Article

Microwave-assisted synthesis of hydroxyphenyl nitrones with protective action against oxidative stress

Journal

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 58, Issue -, Pages 44-49

Publisher

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2012.09.044

Keywords

Hydroxyphenyl nitrones; Microwave-assisted synthesis; Alpha-synuclein; SH-SY5Y human neuroblastoma cells; Primary neural cell

Funding

  1. Agencia Nacional de Investigacion e Innovacion (ANII, Fondo Clemente Estable 491)
  2. Comision Sectorial de Investigacion Cientifica (CSIC)-UdelaR [417]
  3. PEDECIBA-Quimica and project agreement UdelaR (Uruguay)-CSIC (Spain) [20091JY0006]
  4. Ministerio de Ciencia y Tecnologia (Spain) [SAF2010-16365, SAF2009-13015-C02-01]
  5. CSIC (JAE program)

Ask authors/readers for more resources

Oxidative stress plays an important role in neuronal death in neurodegenerative disorders such as Parkinson's disease (PD). Hydroxyphenyl nitrones, derivatives of the nitrone spin trap alpha-phenyl-N-tert-butylnitrone (PBN), were synthesized and their antioxidant, anti-inflammatory and neuroprotective activity in neural cells evaluated. These hydroxyphenyl nitrones 5-7 were synthesized by reaction of the corresponding hydroxybenzaldehyde with N-tert-butyl hydroxylamine under microwave irradiation. They showed good peroxyl free radical scavenger capacities, analyzed by oxygen radical absorbance capacity (ORAC). Also inhibited peroxynitrite-mediated tyrosine nitration of alpha-synuclein in vitro and protected human neuroblastoma (SH-SY5Y) cells against SIN-1 and 6-OHDA toxicity when micromolar concentrations were used. Besides, the hydroxyphenyl nitrones evaluated showed anti-inflammatory activity modulating nitrite production in primary neural cell cultures of astrocytes and microglia treated with lipopolysaccharide (LPS), a potent inflammatory agent. These experimental data suggest a potential therapeutic use of these hydroxyphenyl nitrones against oxygen and nitrogen reactive species involved in neurodegenerative pathology. (C) 2012 Elsevier Masson SAS. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Chemistry, Medicinal

Kinase Inhibitors as Underexplored Antiviral Agents

Javier Garcia-Carceles, Elena Caballero, Carmen Gil, Ana Martinez

Summary: Viral infections are a significant health issue that requires novel therapeutic strategies. Targeting viral proteins encoded by the viral genome with antivirals usually leads to drug resistance. One potential solution is to target host-based proteins and phosphorylation events that play crucial roles in the viral life cycle. Repurposing existing kinase inhibitors could help in terms of cost and effectiveness, but specific medicinal chemistry programs are still needed for better results.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Cell Biology

Neuroprotective properties of queen bee acid by autophagy induction

Guadalupe Martinez-Chacon, Marta Paredes-Barquero, Sokhna M. S. Yakhine-Diop, Elisabet Uribe-Carretero, Ariadna Bargiela, Maria Sabater-Arcis, Jose Morales-Garcia, Jesus Alarcon-Gil, Eva Alegre-Cortes, Saray Canales-Cortes, Mario Rodriguez-Arribas, Pedro Javier Camello, Jose Manuel Bravo-San Pedro, Ana Perez-Castillo, Ruben Artero, Rosa A. Gonzalez-Polo, Jose M. Fuentes, Mireia Niso-Santano

Summary: QBA is a novel autophagy inducer that triggers autophagy in various neuronal cell lines and mouse and fly models. The beclin-1 (BECN1) and mTOR pathways participate in the regulation of QBA-induced autophagy. Moreover, QBA stimulates SIRT1, which promotes autophagy by the deacetylation of critical ATG proteins. QBA-mediated autophagy promotes neuroprotection in Parkinson's disease in vitro and in a mouse model and extends the lifespan of Drosophila melanogaster.

CELL BIOLOGY AND TOXICOLOGY (2023)

Article Chemistry, Medicinal

TDP-43 Modulation by Tau-Tubulin Kinase 1 Inhibitors: A New Avenue for Future Amyotrophic Lateral Sclerosis Therapy

Vanesa Nozal, Loreto Martinez-Gonzalez, Marta Gomez-Almeria, Claudia Gonzalo-Consuegra, Paula Santana, Apirat Chaikuad, Eva Perez-Cuevas, Stefan Knapp, Daniel Lietha, David Ramirez, Sabrina Petralla, Barbara Monti, Carmen Gil, Angeles Martin-Requero, Valle Palomo, Eva de Lago, Ana Martinez

Summary: Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by the aggregation of protein TDP-43. In this study, TTBK1 inhibitors were identified as a promising therapeutic strategy for ALS. The novel pyrrolopyrimidine derivatives demonstrated their ability to reduce TDP-43 phosphorylation and preserve motor neurons in mouse models, suggesting their potential for future ALS therapy.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Microbiology

New insights into the role of endosomal proteins for African swine fever virus infection

Miguel Angel Cuesta-Geijo, Isabel Garcia-Dorival, Ana del Puerto, Jesus Urquiza, Inmaculada Galindo, Lucia Barrado-Gil, Fatima Lasala, Ana Cayuela, Carlos Oscar S. Sorzano, Carmen Gil, Rafael Delgado, Covadonga Alonso

Summary: The inner viral membrane proteins of African swine fever virus (ASFV) interact with endosomal proteins, potentially playing a crucial role in the viral entry process. Silencing or knockout of these proteins affects different stages of ASFV infection, and in some cases, prevents the virus from entering the cytoplasm from endosomes. These findings provide new insights into the role of endosomal proteins in ASFV infection.

PLOS PATHOGENS (2022)

Article Biochemistry & Molecular Biology

Insights into the Pharmacokinetics and In Vitro Cell-Based Studies of the Imidazoline I-2 Receptor Ligand B06

Andrea Bagan, Jose A. Morales-Garcia, Christian Grinan-Ferre, Caridad Diaz, Jose Perez del Palacio, Maria C. Ramos, Francisca Vicente, Belen Perez, Jose Brea, Maria Isabel Loza, Merce Pallas, Carmen Escolano

Summary: The research indicates that modulating imidazoline I-2 receptors can improve cognitive impairment and behavioral condition in patients with neurodegenerative diseases, with representative compound B06 showing potential as a drug candidate for advancing in drug discovery.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemistry & Molecular Biology

Naphthoquinone as a New Chemical Scaffold for Leishmanicidal Inhibitors of Leishmania GSK-3

Victor Sebastian-Perez, Paula Martinez de Iturrate, Montserrat Nacher-Vazquez, Luis Novoa, Concepcion Perez, Nuria E. Campillo, Carmen Gil, Luis Rivas

Summary: A study has identified novel inhibitors of Leishmania GSK-3 with strong antiparasitic activity and in vitro enzyme inhibition, laying the foundation for the development of potential drugs for leishmaniasis.

BIOMEDICINES (2022)

Article Microbiology

The structural role of SARS-CoV-2 genetic background in the emergence and success of spike mutations: The case of the spike A222V mutation

Tiziana Ginex, Clara Marco-Marin, Mitosz Wieczor, Carlos P. Mata, James Krieger, Paula Ruiz-Rodriguez, Maria Luisa Lopez-Redondo, Clara Frances-Gomez, Roberto Melero, Carlos Oscar Sanchez-Sorzano, Marta Martinez, Nadine Gougeard, Alicia Forcada-Nadal, Sara Zamora-Caballero, Roberto Gozalbo-Rovira, Carla Sanz-Frasquet, Rocio Arranz, Jeronimo Bravo, Vicente Rubio, Alberto Marina, Ron Geller, Inaki Comas, Carmen Gil, Mireia Coscolla, Modesto Orozco, Jose Luis Llacer, Jose-Maria Carazo

Summary: This article investigates the impact of the S:A222V mutation on viral infection, and finds that it promotes the opening of RBD and slightly increases ACE2 binding, while not affecting vaccine effectiveness.

PLOS PATHOGENS (2022)

Article Pharmacology & Pharmacy

Network pharmacology reveals multitarget mechanism of action of drugs to be repurposed for COVID-19

Melissa Alegria-Arcos, Tabata Barbosa, Felipe Sepulveda, German Combariza, Janneth Gonzalez, Carmen Gil, Ana Martinez, David Ramirez

Summary: The COVID-19 pandemic has accelerated the development of drugs/vaccines by integrating scientists globally. In this study, researchers collected information on the interactions between proteins from SARS-CoV-2 and humans, as well as information on protein-drug interactions from public databases. By representing this data as networks, they were able to gain insights into the interactions between proteins from both organisms. Through data analysis, they identified important proteins and drugs from a network pharmacology perspective, suggesting potential therapeutic options for COVID-19. This study also revealed the potential importance of human proteins in drug repurposing campaigns.

FRONTIERS IN PHARMACOLOGY (2022)

Article Biochemistry & Molecular Biology

Multitarget drugs as potential therapeutic agents for alzheimer's disease. A new family of 5-substituted indazole derivatives as cholinergic and BACE1 inhibitors

Pedro Gonzalez-Naranjo, Concepcion Perez, Marina Gonzalez-Sanchez, Adrian Gironda-Martinez, Eugenia Ulzurrun, Fernando Bartolome, Marcos Rubio-Fernandez, Angeles Martin-Requero, Nuria E. Campillo, Juan A. Paez

Summary: This study describes a new family of 5-substituted indazole derivatives with a multitarget profile including cholinesterase and BACE1 inhibition, which is a promising therapeutic approach against Alzheimer's disease. The compounds were synthesized and evaluated, and the results showed that some of them have antioxidant, anti-inflammatory, and neuroprotective properties.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2022)

Article Medicine, General & Internal

Efficacy of Bromhexine versus Standard of Care in Reducing Viral Load in Patients with Mild-to-Moderate COVID-19 Disease Attended in Primary Care: A Randomized Open-Label Trial

Maria Luz Vila Mendez, Carmen Anton Sanz, Alicia del Rocio Cardenas Garcia, Amparo Bravo Malo, Francisco Javier Torres Martinez, Jose Maria Martin Moros, Maria Real Torrijos, Jose Francisco Javier Vendrell Covisa, Olga Guzman Sierra, Veronica Molina Barcena, Nuria Viejo Pinero, Carlos Fernandez Diaz, Purificacion Arroyo Burguillo, Ana Maria Blanco Gallego, Carmen Guirao Sanchez, Aranzazu Montilla Bernabe, Maria del Pilar Villanueva Moran, Salvador Juarez Anton, Angela Fernandez Rodriguez, Maria angeles Somoza Calvo, Ernesto Cerrada Cerrada, Gemma Perez Manas, Antonio Sanchez Calso, Frida Vallejo Somohano, Carmen Cauqui Diaz, Gloria Vinas Fernandez, Jesus Molina Paris, Marina Gonzalez Godoy, Gonzalo Lumbreras Garcia, Javier Rosado Martin, Aida Rodriguez Hernandez, Sara Lopez Antunez, Gabriel Vazquez Perfecto, Maria Concepcion Marcello Andres, Nieves Marina Puente Garcia, Carmen Gil, Ana Martinez, Begona Soler Lopez

Summary: This 28-day study compared the efficacy of bromhexine plus standard of care (SOC) to SOC alone in mild-to-moderate COVID-19 outpatients in primary health care settings. The results showed that bromhexine treatment was associated with a reduction in viral load on day 4, but there was no significant difference compared to SOC alone. Therefore, bromhexine may not be an effective antiviral in patients with COVID-19.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Biochemistry & Molecular Biology

To Target or Not to Target Schistosoma mansoni Cyclic Nucleotide Phosphodiesterase 4A?

Yang Zheng, Susanne Schroeder, Georgi K. Kanev, Sanaa S. Botros, Samia William, Abdel-Nasser A. Sabra, Louis Maes, Guy Caljon, Carmen Gil, Ana Martinez, Irene G. Salado, Koen Augustyns, Ewald Edink, Maarten Sijm, Erik de Heuvel, Iwan J. P. de Esch, Tiffany van der Meer, Marco Siderius, Geert Jan Sterk, David Brown, Rob Leurs

Summary: This study investigated the potential of Schistosoma mansoni phosphodiesterase SmPDE4A as a new drug target for schistosomiasis. The researchers cloned, isolated, and characterized the full-length and catalytic domains of SmPDE4A. They found that SmPDE4A resembles human PDE4 more than parasite PDEs. Screening of PDE inhibitors identified tetrahydrophthalazinones and benzamides as potential hits, but further evaluation showed that the inhibitors were not effective against S. mansoni, suggesting that SmPDE4A is not a suitable target for anti-schistosomiasis therapy.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Chemistry, Medicinal

N?-Phenylacetohydrazide Derivatives as Potent Ebola Virus Entry Inhibitors with an Improved Pharmacokinetic Profile

Alfonso Garcia-Rubia, Fatima Lasala, Tiziana Ginex, Marcos Morales-Tenorio, Catherine Olal, Michelle Heung, Paola Oquist, Inmaculada Galindo, Miguel Aprimengel Cuesta-Geijo, Jose M. Casasnovas, Nuria E. Campillo, Angeles Canales, Covadonga Alonso, Ana Martinez, Cesar Munoz-Fontela, Rafael Delgado, Carmen Gil

Summary: Ebola virus (EBOV), a single-strand RNA virus in the Filoviridae family, has been responsible for significant outbreaks since 2013. In this study, a new series of compounds were synthesized and found to inhibit EBOV infection by acting as virus entry inhibitors. The compounds were evaluated for their inhibitory activity against surrogate models and replicative EBOV, and their biological target was elucidated through various experiments. Additionally, their therapeutic potential was confirmed through in vitro metabolic stability and in vivo pharmacokinetic studies.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Cell Biology

Changes in Liver Lipidomic Profile in G2019S-LRRK2 Mouse Model of Parkinson's Disease

Yaiza Corral Nieto, Sokhna M. S. Yakhine-Diop, Paula Moreno-Cruz, Laura Manrique Garcia, Amanda Gabrielly Pereira, Jose A. Morales-Garcia, Mireia Niso-Santano, Rosa A. Gonzalez-Polo, Elisabet Uribe-Carretero, Sylvere Durand, Maria Chiara Maiuri, Marta Paredes-Barquero, Eva Alegre-Cortes, Saray Canales-Cortes, Adolfo Lopez de Munain, Jordi Perez-Tur, Ana Perez-Castillo, Guido Kroemer, Jose M. Fuentes, Jose M. Bravo-San Pedro

Summary: Using mass spectrometry, this study identified metabolic changes in the liver of mouse models of Parkinson's disease, with the aim of finding new peripheral biomarkers for diagnosis.

CELLS (2023)

Article Biochemistry & Molecular Biology

The Dual PDE7-GSK3β Inhibitor, VP3.15, as Neuroprotective Disease-Modifying Treatment in a Model of Primary Progressive Multiple Sclerosis

Rocio Benitez-Fernandez, Carmen Gil, Carmen Guaza, Leyre Mestre, Ana Martinez

Summary: Multiple sclerosis (MS) is a chronic disease that is difficult to treat. This study found that VP3.15 has the potential to treat primary progressive multiple sclerosis (PPMS) by improving the disease course and motor function in infected mice.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Chemistry, Medicinal

Highly potent dual-targeting angiotensin-converting enzyme 2 (ACE2) and Neuropilin-1 (NRP1) peptides: A promising broad-spectrum therapeutic strategy against SARS-CoV-2 infection

Shuang Mei, Su Jiang, Yuting Wang, Han Jing, Peng Yang, Miao-Miao Niu, Jindong Li, Kai Yuan, Yan Zhang

Summary: This study identifies a dual-targeting peptide, AP-1, that effectively inhibits variants of concern (VOCs) of SARS-CoV-2 without impairing host cell viability. The findings suggest that AP-1 could be a promising broad-spectrum agent for treating emerging VOCs of SARS-CoV-2.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Discovery of proteolysis-targeting chimera targeting undruggable proteins using a covalent ligand screening approach

Hyeonjun Lee, Ju Yeon Lee, Hyunsoo Jang, Hye Young Cho, Minhee Kang, Sang Hyun Bae, Suin Kim, Eunji Kim, Jaebong Jang, Jin Young Kim, Young Ho Jeon

Summary: By using liquid chromatography-tandem mass spectrometry and nuclear magnetic resonance experiments, we identified new chemical moieties that bind to the target sites of the protein of interest, allowing for reversible binding and protein degradation. This method has the potential to expand the application of PROTAC technology.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

A pro-death autophagy-based nanoplatform for enhancing antitumour efficacy with improved immune responses

Yingying Li, Xiyou Du, Xinru Kong, Yuelin Fang, Zhijing He, Dongzhu Liu, Hang Wu, Jianbo Ji, Xiaoye Yang, Lei Ye, Guangxi Zhai

Summary: This study proposes a novel nanoplatform based on the autophagy cascade to overcome the obstacles in chemo-immunotherapy. The platform combines chemotherapy and starvation therapy to initiate pro-death autophagy and enhance antigen presentation, while also remodeling the immunosuppressive tumor microenvironment. Furthermore, the study discovers a new therapeutic direction for the respiration inhibitor 3-bromopyruvic acid (3BP) in cancer treatment. Overall, this study offers an opportunity to improve antitumor efficacy and boost immune responses.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

A novel scaffold long-acting selective estrogen receptor antagonist and degrader with superior preclinical profile against ER plus breast cancer

Bingsi Wang, Mingxu Ma, Yusen Dai, Pengfei Yu, Liang Ye, Wenyan Wang, Chunjie Sha, Huijie Yang, Yingjie Yang, Yunjing Zhu, Lin Dong, Shujuan Wei, Linlin Wang, Jingwei Tian, Hongbo Wang

Summary: Breast cancer is a common malignant tumor in women, and drug resistance remains a clinical challenge. In this study, a novel compound, G-5b, was developed with potent antagonistic and degradation activities comparable to the current drug fulvestrant. G-5b also showed improved stability and solubility. Mechanistically, G-5b engages the proteasome pathway to degrade ER, inhibiting the ER signaling pathway and inducing apoptosis and cell cycle arrest. In animal models, G-5b exhibited superior pharmacokinetics and pharmacodynamics properties. Overall, G-5b is a promising long-acting SERD worthy of further investigation and optimization.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents

Karoline B. Waitman, Larissa C. de Almeida, Marina C. Primi, Jorge A. E. G. Carlos, Claudia Ruiz, Thales Kronenberger, Stefan Laufer, Marcia Ines Goettert, Antti Poso, Sandra V. Vassiliades, Vinicius A. M. de Souza, Monica F. Z. J. Toledo, Neuza M. A. Hassimotto, Michael D. Cameron, Thomas D. Bannister, Leticia Costa-Lotufo, Joa o A. Machado-Neto, Mauricio T. Tavares, Roberto Parise-Filho

Summary: A series of hybrid inhibitors combining pharmacophores of known kinase inhibitors and benzohydroxamate HDAC inhibitors were synthesized and evaluated for their anticancer activity and pharmacokinetic properties. Compounds 4d-f exhibited promising cytotoxicity against hematological cells and moderate activity against solid tumor models. Compound 4d showed potent inhibition of multiple kinase targets and had stable interactions with HDAC and members of the JAK family. These compounds showed selective cytotoxicity with minimal effects on non-tumorigenic cells and favorable pharmacokinetic profiles.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Unexpected rearrangement of ivermectin in the synthesis of new derivatives with trypanocidal and antiplasmodial activities

Michal Sulik, Diana Fontinha, Dietmar Steverding, Szymon Sobczak, Michal Antoszczak, Miguel Prudencio, Adam Huczynski

Summary: This study describes the synthesis of the first-in-class ivermectin derivatives obtained through derivatization of the C13 position, along with the unexpected rearrangement of the macrolide ring. These derivatives show potential for antiparasitic activity and are important for the development of new antiparasitic agents.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Novel ligustilide derivatives target quorum sensing system LasR/LasB and relieve inflammatory response against Pseudomonas aeruginosa infection

Jun Liu, Qiu-Xian Chen, Wen-Fu Wu, Dong Wang, Si -Yu Zhao, Jia-Hao Li, Yi-Qun Chang, Shao-Gao Zeng, Jia-Yi Hu, Yu-Jie Li, Jia-Xin Du, Shu-Meng Jiao, Hai-Chuan Xiao, Qiang Zhang, Jun Xu, Jian-Fu Zhao, Hai -Bo Zhou, Yong-Heng Wang, Jian Zou, Ping-Hua Sun

Summary: A new anti-infective drug strategy has been discovered to attenuate virulence and modulate inflammation caused by drug-resistant Pseudomonas aeruginosa infections. Compound 5f inhibits biofilm formation, macrophage migration, and inflammatory response induced by P. aeruginosa, showing potential as a novel candidate against drug-resistant infections.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Design and synthesis of pterostilbene derivatives bearing triazole moiety that might treat DSS-induced colitis in mice through modulation of NF-KB/ MAPK signaling pathways

Liuzeng Chen, Ke Wang, Lingyun Wang, Wei Wang, Lifan Wang, Jia Li, Xiaohan Liu, Mengya Wang, Banfeng Ruan

Summary: In this study, a series of novel anti-inflammatory compounds were designed and synthesized based on the natural product pterostilbene skeleton. Among them, compound 8 showed the highest activity and exhibited its effects through inhibition of pro-inflammatory cytokines by blocking the NF-KB/MAPK signaling pathway. Compound 8 also demonstrated a good relieving effect on acute colitis in mice and showed good safety in acute toxicity experiments.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Discovery of 4-(N-dithiobenzyl piperazine)-1,8-naphthalimide as a potent multi-target antitumor agent with good efficacy, limited toxicity, and low resistance

Si-Min Liang, Gui-Bin Liang, Hui-Ling Wang, Hong Jiang, Xian-Li Ma, Jian-Hua Wei, Ri-Zhen Huang, Ye Zhang

Summary: A series of novel multi-target antitumor agents were designed, synthesized, and evaluated. Some compounds exhibited significant antitumor activity and one compound showed excellent efficacy, limited toxicity, and low resistance. Further mechanism studies revealed that the compound exerted antitumor effects through multiple pathways.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)